TrialFind
Saved trials
Back to results
Completed
Phase 3
A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
NCT02111564
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Birmingham, Alabama, United States
+593 additional locations
View on ClinicalTrials.gov
Official details